Depreciation of Apellis Pharmaceuticals, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Apellis Pharmaceuticals, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Apellis Pharmaceuticals, Inc. Depreciation for the quarter ending 31 Mar 2025 was $446,000, a 0.45% increase year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2025 was $1,558,000, a 13% decline from 2024.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2024 was $1,797,000, a 0.73% increase from 2023.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2023 was $1,784,000, a 15% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Apellis Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,558,000 -$239,000 -13% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $1,797,000 +$13,000 +0.73% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $1,784,000 +$232,000 +15% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $1,552,000 +$173,000 +13% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $1,379,000 +$742,000 +116% 01 Jan 2021 31 Dec 2021 10-K/A 29 Feb 2024 2023 FY
2020 $637,000 +$397,000 +165% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $240,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY

Apellis Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $446,000 +$2,000 +0.45% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $444,000 +$23,000 +5.5% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $421,000 +$44,000 +12% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $377,000 +$95,000 +34% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $282,000 +$197,000 +232% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $85,000 +$44,000 +107% 01 Jan 2020 31 Mar 2020 10-Q 28 Apr 2021 2021 Q1
Q1 2019 $41,000 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.